Graft-versus-Host Disease: What to Know, What to Do

Select Option: 

© October, 2023

Author:   Susan Stewart

Illustrations:  Norm Bendell

Medical Advisors: Amin Alousi MD, The University of Texas MD Anderson Cancer Center; Michelle Bishop PhD, Coping with Cancer and Caregiving;  Joseph Bubalo PharmD, Oregon Health & Science University; Corey Cutler MD, MPH, FRCPC, Dana-Farber Cancer Institute; Sharon Hymes MD, The University of Texas MD Anderson Cancer Center; Stephanie J. Lee MD, MPH, Fred Hutchinson Cancer Center; Zhongui Katie Luo MD, PhD, Massachusetts Eye and Ear; Navneet Majhail MD, MS, Sarah Cannon Transplant and Cellular Therapy Network; Steven Z. Pavletic MD, MS, National Cancer Institute; and Nathaniel S. Treister DMD, DMSc, Brigham and Women's Hospital/Dana-Farber Cancer Institute

Graft-versus-host disease (GVHD) is a complication that often occurs after a transplant using cells from a donor (an allogeneic transplant).  This booklet will help you understand:

  • the symptoms of GVHD
  • the organs it can affect
  • treatment options
  • steps you can take to minimize the impact of GVHD on your daily life.

Managing GVHD requires a close working relationship between you and your healthcare team.  The more you know, the better equipped you will be to take charge of your GVHD.

Click here to order a GVHD booklet in Spanish.

Many thanks to Sanofi and Incyte Corporation whose support, made this publication possible.